Detection of PatIent-Level distances from single cell genomics and pathomics data with Optimal Transport (PILOT).
Mehdi JoodakiMina ShaiganVictor ParraRoman David BülowChristoph KuppeDavid L HölscherMingbo ChengJames S NagaiMichaël GoedertierNassim BouteldjaVladimir TesarJonathan BarrattIan Sd RobertsRosanna CoppoRafael KramannPeter BoorIvan G CostaPublished in: Molecular systems biology (2023)
Although clinical applications represent the next challenge in single-cell genomics and digital pathology, we still lack computational methods to analyze single-cell or pathomics data to find sample-level trajectories or clusters associated with diseases. This remains challenging as single-cell/pathomics data are multi-scale, i.e., a sample is represented by clusters of cells/structures, and samples cannot be easily compared with each other. Here we propose PatIent Level analysis with Optimal Transport (PILOT). PILOT uses optimal transport to compute the Wasserstein distance between two individual single-cell samples. This allows us to perform unsupervised analysis at the sample level and uncover trajectories or cellular clusters associated with disease progression. We evaluate PILOT and competing approaches in single-cell genomics or pathomics studies involving various human diseases with up to 600 samples/patients and millions of cells or tissue structures. Our results demonstrate that PILOT detects disease-associated samples from large and complex single-cell or pathomics data. Moreover, PILOT provides a statistical approach to find changes in cell populations, gene expression, and tissue structures related to the trajectories or clusters supporting interpretation of predictions.
Keyphrases
- single cell
- rna seq
- high throughput
- gene expression
- study protocol
- electronic health record
- induced apoptosis
- depressive symptoms
- big data
- high resolution
- endothelial cells
- cell cycle arrest
- randomized controlled trial
- machine learning
- ejection fraction
- end stage renal disease
- newly diagnosed
- clinical trial
- prognostic factors
- cell death
- endoplasmic reticulum stress
- patient reported outcomes
- artificial intelligence
- mass spectrometry
- quantum dots
- signaling pathway
- deep learning
- pluripotent stem cells